These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 31865490)

  • 1. Successful Pregnancies After Regression of AA Amyloidosis by Anti-inflammatory Therapy in Chronic Active Crohn's Disease.
    Blesl A; Rainer F; Pollheimer M; Kump P; Durchschein F; Wenzl H; Eller K; Krisper P; Petritsch W; Högenauer C
    Dig Dis Sci; 2020 Sep; 65(9):2730-2734. PubMed ID: 31865490
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of infliximab induction therapy on secondary systemic amyloidosis associated with Crohn's disease: case report and review of the literature.
    Pukitis A; Zake T; Groma V; Ostrovskis E; Skuja S; Pokrotnieks J
    J Gastrointestin Liver Dis; 2013 Sep; 22(3):333-6. PubMed ID: 24078992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic secondary amyloidosis in a 70-year-old patient with Crohn's disease: treatment with oral budesonide.
    Wang Y; Lee H; Shen B
    Inflamm Bowel Dis; 2013 Apr; 19(5):E74-5. PubMed ID: 23478807
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy of scheduled infliximab maintenance therapy on systemic amyloidosis associated with crohn's disease.
    Iizuka M; Sagara S; Etou T
    Inflamm Bowel Dis; 2011 Jul; 17(7):E67-8. PubMed ID: 21509909
    [No Abstract]   [Full Text] [Related]  

  • 5. [An unexplained inflammatory syndrome could be due to renal amyloidosis associated to Crohn's disease].
    Fekih M; Hefaiedh R; Matri S; Djebbi S; Boubaker J; Filali A
    Tunis Med; 2008 Nov; 86(11):1022-3. PubMed ID: 19213504
    [No Abstract]   [Full Text] [Related]  

  • 6. Secondary amyloidosis in a patient with long duration Crohn's disease treated with infliximab.
    Fidalgo C; Calado J; Cravo M
    BioDrugs; 2010 Dec; 24 Suppl 1():15-7. PubMed ID: 21175229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infiximab for treatment of systemic amyloidosis associated with Crohn's disease.
    Said Y; Debbeche R; Hamzaoui L; Lounissi M; Trabelsi S; Bouzaidi S; Salem M; Abdelmoula L; Najjar T
    J Crohns Colitis; 2011 Apr; 5(2):171-2. PubMed ID: 21453891
    [No Abstract]   [Full Text] [Related]  

  • 8. Crohn's disease and secondary amyloidosis: early complication? A case report and review of the literature.
    Basturk T; Ozagari A; Ozturk T; Kusaslan R; Unsal A
    J Ren Care; 2009 Sep; 35(3):147-50. PubMed ID: 19689697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crohn's ileitis complicated by amyloidosis: observations and therapeutic considerations.
    Becker SA; Bass D; Nissim F
    J Clin Gastroenterol; 1985 Aug; 7(4):296-300. PubMed ID: 2864372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammatory bowel disease and systemic AA amyloidosis.
    Sattianayagam PT; Gillmore JD; Pinney JH; Gibbs SD; Wechalekar AD; Gilbertson JA; Rowczenio D; Hawkins PN; Lachmann HJ
    Dig Dis Sci; 2013 Jun; 58(6):1689-97. PubMed ID: 23371008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complete remission of nephrotic syndrome secondary to amyloid a amyloidosis in patient with inactive Crohn's disease after treatment by infliximab.
    Hassani K; Hamzi MA; El Kabbaj D
    Saudi J Kidney Dis Transpl; 2018; 29(2):456-461. PubMed ID: 29657220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infliximab in the treatment of amyloidosis secondary to Crohn's disease.
    Cabezuelo JB; Egea JP; Ramos F; Torrella E; Muray S; Alcázar C
    Nefrologia; 2012 May; 32(3):385-8. PubMed ID: 22592423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-TNF-α therapy for renal amyloid as a complication of Crohn's disease.
    Blackmur JP; Chapman FA; Bellamy CO; Save V; Plevris JN; Shand AG; Whitworth C; Dhaun N
    QJM; 2014 Jan; 107(1):57-9. PubMed ID: 23681221
    [No Abstract]   [Full Text] [Related]  

  • 14. [Good response to colchicine in amyloidosis secondary to inflammatory bowel disease].
    Garrido Serrano A; Guerrero Igea FJ; Hierro Guilmain C; Ruiz Lupiáñez E; Palomo Gil S
    Gastroenterol Hepatol; 2001 Apr; 24(4):196-8. PubMed ID: 11333657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal amyloidosis after a short period since diagnosis of ileocolonic Crohn's disease.
    Karaahmet F; Akinci H; Hamamci M; Bahceci M; Coban S; Yuksel I
    J Gastrointestin Liver Dis; 2013 Dec; 22(4):473-4. PubMed ID: 24369336
    [No Abstract]   [Full Text] [Related]  

  • 16. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
    Nørgård BM
    Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful use of maintenance infliximab for nephropathy in a patient with secondary amyloidosis complicating Crohn's disease.
    Tada Y; Ishihara S; Ito T; Matsui K; Sonoyama H; Oka A; Kusunoki R; Fukuba N; Mishima Y; Oshima N; Moriyama I; Yuki T; Kawashima K; Sato S; Adachi K; Ikeuchi H; Kinoshita Y
    Intern Med; 2013; 52(17):1899-902. PubMed ID: 23994979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Orofacial granulomatosis as first manifestation of Crohn's disease: successful treatment of both conditions with a combination of infliximab and dapsone.
    Kemmler N; Pfannschmidt N; Strohal R
    Acta Derm Venereol; 2012 Jul; 92(4):406-7. PubMed ID: 22113308
    [No Abstract]   [Full Text] [Related]  

  • 19. Crohn's disease associated with renal amyloidosis successfully treated with an elemental diet.
    Horie Y; Chiba M; Miura K; Iizuka M; Masamune O; Komatsuda A; Ebina T
    J Gastroenterol; 1997 Oct; 32(5):663-7. PubMed ID: 9349994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Early amyloidosis in Crohn's disease].
    Martínez Salazar F; Lacruz Rodrigo J; Muñoz Guillen ML; Calabuig Alborch JR
    An Med Interna; 1990 Nov; 7(11):604. PubMed ID: 2103224
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.